Acquisitions1 Jul 2026, 06:30 pm
Lupin Subsidiary MPPI Completes Share Acquisition and Buyback
AI Summary
Lupin Ltd announced that its wholly owned subsidiary, Nanomi B.V., has successfully completed the acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc. (MPPI). Additionally, MPPI has completed a buy-back of 61,118 shares, with the process for the remaining 30,559 shares ongoing. These transactions have significantly increased Nanomi's shareholding in MPPI from 56.28% to 99.89% as of July 01, 2026. This move consolidates Lupin's control over its Philippine subsidiary, potentially streamlining operations and strategic decision-making.
Key Highlights
- Nanomi B.V. acquired minority shares in subsidiary MPPI.
- MPPI completed buyback of 61,118 shares; 30,559 pending.
- Nanomi's stake in MPPI increased to 99.89% from 56.28%.
- Consolidation of control over the Philippine subsidiary.
Price Impact
More from LUPIN